Changes in medical and surgical treatments of glaucoma between 1997 and 2003 in France

European Journal of Ophthalmology

Volumn 17, Issue 4, 2007, Pages 521-527

  Kenigsberg, Paul Ariel ^a  

^a PAK Santé   (France)

Author keywords

Bimatoprost; Brimonidine; Brinzolamide; Dorzolamide; Glaucoma; Latanoprost; Prostaglandins; Surgery; Trabeculectomy; Travoprost

Indexed keywords

BIMATOPROST; BRINZOLAMIDE; DORZOLAMIDE; LATANOPROST; PROSTAGLANDIN; TIMOLOL; TRAVOPROST;

ARTICLE; CONTROLLED STUDY; FRANCE; GLAUCOMA; GLAUCOMA SURGERY; HOSPITALIZATION; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; TRABECULECTOMY; TREATMENT PLANNING;

EID: 35348946363     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700407     Document Type: Article

References (24)

1. Alward WLM. Medical management of glaucoma. N Engl J Med 1998; 339: 1298-307.
2. Kass MA, Heuer DK, Higginbotham EJ, et al. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. The Ocular Hypertension Treatment Study. Arch Ophthalmol 2002; 120: 701-13.
3. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-40.
4. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-97.
5. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498-505.
6. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 111: 51-5.
7. Terminology and guidelines for glaucoma, 2nd ed. European Glaucoma Society. Dogma, 2003; 34.
8. Béchetoille A. Les Glaucomes, volume 2. Japperenard: Angers; 2000: 279-324.
9. Hamard R Lachkar Y. La chirurgie filtrante non-perforante: évolution du concept, réalisation, résultats. J Fr Ophtalmol 2002; 25: 527-36.
10. Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 2002; 11: 214-20.
11. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 2003; 241: 106-10.
12. Suzuki R, Dickens CJ, Iwach AG, et al. Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections. Ophthalmology 2002; 109: 1921-4.
13. Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, et al. Non-penetrating deep sclerectomy: a 6-year retrospective study. Eur J Ophthalmol 2004; 14: 26-36.
14. Ehrnrooth P, Puska R Lehto I, Laatikainen L. Progression of visual field defects and visual loss in trabeculectomized eyes. Graefes Arch Clin Exp Ophthalmol 2005; 243: 741-7.
15. Shingleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology 1993; 100: 1324-9.
16. Ederer F, Gaasterland DA, Dally LG, et al, for the AGIS investigators. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004; 111: 651-64.
17. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121: 48-56.
18. Parc CE, Johnson DH, Oliver JE, Hattenhauer MG, Hodge DO. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 2001; 132: 27-35.
19. Baudouin C, Rouland JF, Le Pen C. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol 2003; 13 (Suppl 4): S53-60.
20. Site officiel du Programme de Médicalisation des Systèmes d'information (PMSI). Available at: http://stats.atih.sante.fr. Accessed November 5, 2003; updated September 29, 2004.
21. Bateman DN, Clark R, Azuara-Blanco A, Bain M, Forrest J. The impact of new drugs on management of glaucoma in Scotland: observational study. BMJ 2001; 323: 1401-2.
22. Bateman DN, Clark R, Azuara-Blanco A, Bain M, Forrest J. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002; 86: 551-4.
23. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998. Ophthalmology 2002; 109: 1372-6.
24. van der Valk R, Schouten JS, Webers CA, et al. The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries. J Glaucoma 2005; 14: 239-42.